Related by context. All words. (Click for frequent words.) 67 % CI #.#-#.# [008] 66 LV dysfunction 65 multivariate adjustment 64 suboptimal adherence 63 gastric cardia 63 CP CPPS 63 comorbid depression 62 cough dyspnea 62 colorectal adenoma 62 Diabetic nephropathy 61 metabolic dysregulation 61 CVD mortality 61 symptomatic intracranial 61 affective psychosis 61 limiting generalizability 61 detrusor overactivity 61 PLX STROKE targeting 61 CTEPH 61 inversely associated 61 autonomic dysfunction 61 polyp recurrence 61 histologic subtype 61 multivariable adjusted 61 Autoimmune hepatitis 61 gastric carcinoma 61 albumin excretion rate 60 cerebral oxygenation 60 comorbid anxiety 60 thrombocytopenic 60 Chlamydia trachomatis infection 60 % CI #.#-#.# [007] 60 preterm neonates 60 headache abdominal pain 60 anagrelide 60 confidence interval #.#-#.# 60 elevated LDH 60 nonobstructive 60 lowest tertile 60 % CI #.#-#.# [006] 60 serum parathyroid hormone 60 elevated ALT 60 Carotid endarterectomy 60 mucosal inflammation 60 CYP#D# inhibitor 60 Hypotension 59 bronchial hyperresponsiveness 59 clinicopathological features 59 completely resected 59 microbiologically evaluable 59 attain statistical significance 59 gestational hypertension 59 postoperative atrial fibrillation 59 hormone receptor negative 59 ß blockers 59 visceral metastases 59 echocardiographic parameters 59 FluCAM arm 59 Combination antiretroviral therapy 59 statistically significant p = 59 highest tertile 59 serum biomarker 59 IPAH 59 Subgroup analyzes 59 nondiabetic patients 59 Multivariate analysis revealed 59 hematopoietic cancers 59 GG genotype 59 locoregional recurrence 59 nonmetastatic 59 parkinsonian symptoms 59 TMP SMX 59 oral anticoagulation 59 arterial thromboembolic events 59 pulmonary dysfunction 59 Stent thrombosis 59 GI toxicity 59 pretransplant 59 thyroid carcinoma 59 TNF blocker therapy 59 recurrent venous thromboembolism 59 hyperlipemia 59 undergo percutaneous coronary 59 serum BDNF 59 CIMZIA TM certolizumab pegol 59 dalteparin 59 familial aggregation 59 carotid plaques 59 gm dl 59 postoperative AF 59 prolactin elevation 59 correlated inversely 59 depressive symptomatology 59 haematologic 59 obstructive CAD 59 hypertension diabetes mellitus 59 HOMA IR 59 mechanically ventilated patients 59 EGFR mutation positive 59 recurrent acute pancreatitis 59 logistic regression analysis 59 extrapulmonary 58 posttransplant 58 Univariate analysis 58 antiretroviral naïve 58 advanced adenoma 58 acute myocardial infarctions 58 deep venous thromboses 58 Endothelial dysfunction 58 P = .# 58 pulmonary capillary wedge 58 initiating antiretroviral therapy 58 oesophageal adenocarcinoma 58 esophageal gastric 58 intima media thickness 58 nonalcoholic steatohepatitis NASH 58 anticholinergic agents 58 oxycodone CR 58 overt nephropathy 58 revascularized 58 diabetic kidney 58 ACEIs 58 atrophic gastritis 58 CC genotype 58 hyperhomocysteinemia 58 pT3 58 chronic rheumatic 58 hippocampal atrophy 58 Tasigna prolongs 58 pulsatility index 58 pneumocystis carinii pneumonia 58 detrusor 58 R entecavir 58 predisposing factor 58 hematological parameters 58 shorter telomere length 58 p = NS 58 -#.# mm Hg 58 symptomatic intracerebral hemorrhage 58 impaired glucose metabolism 58 β blockers 58 antenatal depression 58 GH deficiency 58 Subclinical 58 glycated hemoglobin HbA1c 58 Serum creatinine 58 obstructive coronary artery 58 gastro oesophageal reflux 58 multivariate analyzes 58 recurrent glioblastoma multiforme 58 bacillus Calmette Guerin 58 HIV lipodystrophy 58 glycosylated hemoglobin HbA1c 58 vasopressor 58 pooled comparator 58 HbA1C levels 58 serous ovarian cancer 58 skeletal metastases 58 SGPT 58 comorbid illnesses 58 DHEA supplementation 58 venlafaxine XR 58 nasal polyposis 58 euthymic patients 58 Subgroup analysis 58 mg p = 58 intraventricular hemorrhage 58 transaminase elevations 58 neurocognitive deficits 58 fructose intolerance 58 childhood acute lymphoblastic 58 IOP lowering 58 sociodemographic characteristics 58 Cystatin C 58 p = .# [002] 58 unstable angina pectoris 58 thromboembolic 57 receiving XGEVA 57 cirrhotic 57 median survivals 57 diabetes mellitus DM 57 salmeterol fluticasone 57 VTE prophylaxis 57 latent celiac disease 57 calcium antagonist 57 left ventricular diastolic 57 titrated glipizide 57 lymphomas leukemias 57 perineural invasion 57 Erythropoietic therapies may 57 perioperatively 57 nadroparin 57 pT2 57 primary aldosteronism 57 glycaemia 57 OSAHS 57 mild renal insufficiency 57 hemodynamically stable 57 Myocardial infarction 57 visceral adiposity 57 hemorrhagic cystitis 57 de novo AML 57 aspartate aminotransferase AST 57 #mg/day [001] 57 spirometric 57 somatostatin analog 57 elevated transaminases 57 hydroxyvitamin D concentrations 57 albumin excretion 57 coinfected patients 57 thiopurine 57 glomerular filtration 57 artery stenosis 57 International Prognostic Scoring 57 nonalcoholic steatohepatitis 57 nonhereditary 57 squamous cell lung cancer 57 euthyroid 57 % CI #.#-#.# [003] 57 nonobese patients 57 premorbid 57 angiographically 57 mmHg diastolic 57 tumor histology 57 psoriatic arthritis PsA 57 elevated IOP 57 hepatorenal syndrome 57 macrovascular disease 57 borderline statistical significance 57 perioperative morbidity 57 deletion 5q 57 venous thromboembolic disease 57 receiving ISENTRESS 57 comorbid disorders 57 serum urate levels 57 Exacerbations 57 gonococcal 57 carotid IMT 57 colorectal carcinoma 57 psychosocial functioning 57 neurodevelopmental impairment 57 CI #.#-#.# [002] 57 Urinary tract 57 unresectable HCC 57 bacteriuria 57 epoetin therapy 57 parasitemia 57 CI -#.# 57 spontaneous bacterial peritonitis 57 hypercholesterolaemia 57 salmeterol fluticasone propionate 57 oral prednisolone 57 QTcF 57 endocrine therapies 57 retrograde ejaculation 57 surgically resectable 57 #.#/#.# mmHg [001] 57 localized renal 57 carotid atherosclerosis 57 hyperacute 57 onset diabetes mellitus 57 Transcatheter aortic valve implantation 57 ALSFRS R 57 % CI #.#-#.# [001] 57 LNG IUS 57 cytomegalovirus infection 57 headache nasopharyngitis 57 elevated fasting glucose 57 morphometric vertebral fractures 57 nontraumatic 57 Papillary 57 benign noncancerous 57 serum triglycerides 57 hormone receptor status 57 highest quintile 57 mIU L 57 SLNB 57 hyperlipidaemia 57 Heavy menstrual bleeding 57 Topical corticosteroids 57 glycemic variability 57 villous atrophy 57 tipranavir ritonavir 57 abnormal glucose tolerance 57 achieved ACR# 57 chronic obstructive airways 57 bony metastases 57 allogeneic HSCT 57 Thromboembolic 57 noncardiac 57 cirrhotic patients 57 Chronic pancreatitis 57 symptomatic intracranial hemorrhage 57 serum estradiol 56 neurocognitive impairment 56 fibroids endometriosis 56 atherothrombotic 56 HbA1C 56 TT genotype 56 null responder 56 SORT OUT III 56 Avandia Actos 56 experienced virologic failure 56 Hyperparathyroidism 56 extrapyramidal symptoms 56 recurrent DVT 56 vasoactive 56 overt hypothyroidism 56 Commonly prescribed 56 Multivariate analysis showed 56 vitreous floaters 56 anticholinergic medication 56 abdominal adiposity 56 BPS IC 56 subclinical inflammation 56 Calcium intake 56 isolated systolic hypertension 56 macroalbuminuria 56 Apolipoprotein B 56 psychiatric comorbidity 56 intravesical therapy 56 socioeconomic deprivation 56 postoperative pulmonary 56 stratifying patients 56 peri procedural 56 intact parathyroid hormone 56 antiphospholipid syndrome 56 neutropenia dehydration dyspnea 56 confidence intervals CIs 56 gross hematuria 56 parous women 56 multivariable analysis 56 nonsignificant difference 56 neuritic 56 CI #.#-#.# [001] 56 androgen ablation 56 NMIBC 56 meta analytic review 56 EEG abnormalities 56 relapsed MM 56 colorectal adenomas 56 prospectively stratified 56 elevated LDL cholesterol 56 coinfection 56 ALI ARDS 56 DQB1 * 56 chronic thromboembolic pulmonary 56 pretest probability 56 Genetic predisposition 56 #q# deletion syndrome 56 chronic hepatitis cirrhosis 56 β blocker 56 restenosis reblockage 56 left ventricular systolic 56 histologically confirmed 56 beta carotene supplementation 56 diastolic hypertension 56 undergoing percutaneous coronary 56 Microalbuminuria 56 mL/min/#.# m 2 56 prolonged QT interval 56 bioavailable testosterone 56 transferrin saturation 56 DAS# CRP 56 Elevated serum 56 absolute contraindication 56 postmenopausal hormone 56 decompensated cirrhosis 56 tipranavir r 56 malabsorptive 56 CCyR 56 AGGRASTAT R tirofiban hydrochloride 56 taxane refractory 56 KDOQI 56 p = #.# [003] 56 darunavir r 56 gastroesophageal 56 symptom exacerbation 56 syncope fainting 56 arterial hypertension 56 amisulpride 56 nonnucleoside reverse transcriptase inhibitors 56 Heritability 56 euthymic 56 intracranial atherosclerosis 56 HBeAg seroconversion 56 ventricular tachyarrhythmia 56 Kinoid 56 obstructive sleep 56 residual confounding 56 sensory gating 56 glucocorticoid induced 56 antiphospholipid antibodies 56 FDA defined valvulopathy 56 familial clustering 56 HIV HCV coinfected 56 intravenous diuretics 56 HIV coinfection 56 Chemotherapy induced 56 plasminogen activators 56 recurrent UTI 56 Suicidal ideation 56 postoperative delirium 56 aOR 56 severe exacerbations 56 fructosamine 56 neurologic dysfunction 56 extracapsular extension 56 familial hypercholesterolemia FH 56 underwent prostate biopsy 56 clinically meaningful reductions 56 nonexposed 56 ovarian carcinoma 56 thyrotoxicosis 56 preeclamptic 56 NSTEMI 56 pyrexia mucositis sepsis febrile 56 ischemic vascular 56 Impaired glucose tolerance 56 mediastinitis 56 prostate carcinoma 56 reinfarction 56 elevated TSH 56 acute cholecystitis 56 clot busting therapy 56 diabetes mellitus hypertension 56 haemorrhagic stroke 56 = #.#-#.# 56 embolic stroke 56 univariate analyzes 56 induce orthostatic hypotension 56 hemodynamic variables 56 estimated GFR 56 microangiopathy 56 neurodevelopmental outcome 56 Testosterone deficiency 56 methotrexate monotherapy 56 Depressive symptoms 56 serum lipid levels 56 plasma leptin 56 chronic renal insufficiency 56 HbA 1c levels 56 tertiles 56 sensory neuropathy 56 corticosteroid dose 56 probiotic supplementation 56 juvenile idiopathic arthritis JIA 56 serum GGT 56 Ischemic 56 elevated uric acid 56 antioxidant supplementation 56 inotropic 56 HIV coinfected 56 sternal wound infections 56 gallstone disease 56 amenorrhoea 56 circulating endothelial cells 56 natriuresis 56 inotropes 56 precancerous cervical 56 hypothalamic amenorrhea 56 Cimzia TM 56 mesangial 56 glycosylated hemoglobin levels 55 hepatic liver 55 PSA nadir 55 plus octreotide LAR 55 coronary calcification 55 femoral neck fracture 55 smoldering myeloma 55 Adverse effects 55 nonadherent 55 -#.# mg dL [001] 55 pentoxifylline 55 abacavir Ziagen 55 prostate cancer CaP 55 non cirrhotic portal 55 ventricular remodeling 55 malignant neoplasm 55 fasting plasma 55 myocardial ischaemia 55 Helicobacter pylori eradication 55 containing abacavir 55 abacavir lamivudine 55 linaclotide treated 55 thalassemia sickle cell 55 inhospital mortality 55 serum lactate 55 rimonabant #mg 55 plasma cortisol 55 Bacterial vaginosis 55 Viral load 55 poststroke 55 symptomatic VTE 55 hepatic cirrhosis 55 odds ratios ORs 55 carotid bruit 55 SRBD 55 hepatocellular carcinoma liver 55 leiomyomas 55 Cardiorespiratory fitness 55 elevated serum creatinine 55 nausea emesis 55 infective endocarditis 55 tamoxifen Nolvadex ® 55 metachronous 55 abnormal lipid levels 55 clomipramine 55 AST ALT 55 progressive dyspnea 55 intravascular hemolysis 55 nonpsychotic 55 HF hospitalization 55 inhaled corticosteroids ICS 55 SSc 55 H2RAs 55 hMG 55 Thal Dex 55 Secondary endpoints include 55 proliferative retinopathy 55 postoperative infections 55 PLMs 55 fatigue abdominal pain 55 recurrent myocardial infarction 55 ATACAND 55 depression suicidal ideation 55 distal colon cancer 55 vasogenic edema 55 multivariate Cox 55 Prostate specific antigen 55 cardiopulmonary diseases 55 Homocysteine levels 55 cystic fibrosis chronic pancreatitis 55 squamous histology 55 leukocyte counts 55 lowering blood glucose 55 genital ulcer 55 adjuvant cisplatin 55 baseline LDH 55 elevated triglyceride levels 55 reduce serum phosphate 55 Postmenopausal hormone therapy 55 Relapsing remitting MS 55 uremic 55 pharmacokinetic interaction 55 polytherapy 55 Magnesium deficiency 55 lung resection 55 % Confidence Interval 55 IV bisphosphonates 55 cervicitis 55 HBeAg 55 multifactorial disease 55 lactate dehydrogenase 55 surrogate markers 55 lenalidomide dexamethasone 55 gestational diabetes mellitus GDM 55 HIV uninfected 55 Diastolic 55 cutaneous melanoma 55 SCr 55 Celsentri Selzentry 55 recurrent VTE 55 acute myocardial infarction MI 55 Angiotensin converting enzyme 55 tachyarrhythmias 55 SSRI citalopram 55 refractory anaplastic astrocytoma 55 schizophreniform 55 plasma adiponectin 55 lymphocytosis 55 antiangiogenic therapy 55 bullous 55 Acute Coronary Syndromes ACS 55 oral antidiabetic medication 55 fibrin deposition 55 coronary artery atherosclerosis 55 Prognostic factors 55 lesional 55 intracerebral haemorrhage 55 adenomatous 55 carotid plaque 55 PCWP 55 persistency mortality 55 cardiovascular calcification 55 thyrotropin levels 55 proliferative diabetic retinopathy 55 periprocedural 55 haemodynamic 55 lipid lowering medications 55 HDL cholesterol triglycerides 55 Left ventricular hypertrophy 55 hypertension hypercholesterolemia 55 conventional DMARDs 55 atherothrombotic disease 55 clinicopathological 55 elevated prolactin 55 T1a 55 glycated hemoglobin levels 55 alpha1 antitrypsin deficiency 55 hemodynamic parameters 55 Genetic susceptibility 55 intratympanic 55 baroreflex sensitivity 55 hemorrhagic complications 55 Adjuvant chemotherapy 55 acute mania 55 Breslow thickness 55 Multivariate analyzes 55 serum bicarbonate 55 frequent awakenings 55 lymphovascular invasion 55 plasma lipid 55 smoldering multiple myeloma 55 oral Hycamtin 55 neurocognitive dysfunction 55 bicuspid aortic valves 55 hypovitaminosis D 55 CFQ R 55 Clinically significant 55 systolic hypertension 55 baseline serum creatinine 55 unfavorable cytogenetics 55 baseline HbA1c 55 acute respiratory tract infections 55 Estrogen receptor 55 neuropsychological impairment 55 angiotensin II receptor blockers 55 untreated OSA 55 complete cytogenetic response 55 airflow limitation 55 nodal metastasis 55 angiotensin converting enzyme inhibitors 55 recurrent metastatic 55 G6PD deficiency 55 LV ejection fraction 55 normotensive 55 sociodemographic factors 55 urodynamic parameters 55 recurrent tonsillitis 55 Prognostic significance 55 nonfasting triglyceride levels 55 coagulopathy 55 olanzapine LAI 55 insulin secretagogues 55 A1PI 55 Cardiopulmonary bypass 55 minimally symptomatic 55 anterior temporal 55 posttreatment 55 hyperprolactinemia 55 Flu Cy 55 polymicrobial 55 Hb A1C 55 irritative 55 commonest cause 55 nonsevere 55 antiandrogens 55 dyssynchrony 55 moderate hepatic impairment 55 functional gastrointestinal disorders 55 T1c 55 carotid artery blockage 55 HNSCC 55 mutated KRAS 55 apolipoprotein B 55 leukocyte count 55 inhaled budesonide 55 paraoxonase 55 NHANES III 55 fatigue nausea vomiting 55 leucopenia 55 colorectal neoplasms 55 systolic function 55 Prosaptide 55 irregular menstruation 55 systolic dysfunction 55 hepatocellular 55 Venous thromboembolism 55 atrioventricular block 55 percutaneous vertebroplasty 55 affective psychoses 55 apnea hypopnea 55 aspirin clopidogrel 55 polycythemia vera essential thrombocythemia 55 nonprogressive 55 retransplantation 55 non valvular atrial 55 plasma pharmacokinetics 55 idiopathic intracranial hypertension 55 prospectively evaluated 55 stent binary restenosis 55 LVSD 55 antiarrhythmic 55 HeFH 55 liver metastasis 55 alanine aminotransferase ALT 55 Comorbid 55 Pneumocystis carinii pneumonia 55 cortical atrophy 55 systemic corticosteroid 55 antipsychotic induced 54 schizophreniform disorder 54 de ath 54 dietary folate 54 hyperbilirubinemia 54 liver decompensation 54 lipid elevations 54 post transplant lymphoproliferative 54 alanine aminotransferase 54 GP IIb IIIa 54 fatigue diarrhea nausea 54 Heterozygous Familial Hypercholesterolemia 54 Cypher Stent 54 inflammatory biomarkers 54 systemic hypotension 54 tumor lysis syndrome 54 ADCS CGIC 54 pancreatic ductal 54 NYHA functional class 54 nonvertebral fracture 54 waist circumference WC 54 neutropenia thrombocytopenia 54 reflux esophagitis 54 beta adrenergic receptor 54 psychiatric morbidity 54 retinal vein occlusion induced 54 STRIDE PD 54 Hematologic 54 parenchymal 54 inotropic agents 54 serum homocysteine 54 SIADH 54 Coronary artery bypass graft 54 affective disorders 54 adenoma recurrence 54 clinico pathological 54 neovascular glaucoma 54 arterial oxygen saturation 54 NIDDM 54 arterial thromboembolism 54 primary hyperparathyroidism 54 MetS 54 perioperative mortality 54 riociguat 54 angiotensin receptor blockers ARBs 54 orchitis 54 Zinc supplementation 54 triglyceride concentrations 54 Insulin sensitivity 54 thetreatment 54 Cognitive impairment 54 octreotide LAR 54 nonfatal MI 54 thrombocytosis 54 reproductive tract infections 54 hemodynamically unstable 54 coronary revascularization procedures 54 abnormal lipids 54 nonischemic 54 plasma creatinine 54 cardiac insufficiency 54 congenital deficiency 54 acute renal 54 mutated K ras 54 neurobehavioural 54 overactive bladder symptoms 54 neutrophil counts 54 Helicobacter pylori infection 54 dermatologic reactions 54 AChE inhibitors 54 subsyndromal 54 pCR 54 Ischemic heart 54 Leydig cell 54 nicardipine 54 Oral contraceptive 54 neurological manifestations 54 H pylori infection 54 thromboembolic disease 54 virologic suppression 54 Infusion Reactions Severe 54 ANCOVA 54 cerebrovascular accidents 54 nonmelanoma 54 bladder carcinoma 54 nondepressed 54 enteroviral infection 54 hyperglycaemia 54 bronchogenic carcinoma 54 thrombo embolic 54 doxorubicin docetaxel 54 adiponectin concentrations 54 thiazide 54 Pulmonary hypertension 54 epoetin alpha 54 mammographic breast density 54 axillary node 54 BMI z 54 NIHSS score 54 nasopharyngitis headache 54 Sleep disturbances 54 undergoing liver transplantation 54 habitual snoring 54 SNP rs# [002] 54 x ULN 54 VLBW infants 54 Aceon 54 HER2 overexpression 54 renal scarring 54 Soy isoflavones 54 silent ischemia 54 agonist induced 54 levodopa induced 54 pulmonary exacerbations 54 beta blocker therapy 54 lamivudine refractory patients 54 inflammatory bowel syndrome 54 IM progesterone 54 invasive lobular 54 schizophrenia schizoaffective disorder 54 obstructive coronary 54 hypopneas 54 isoproterenol 54 ischemic lesions 54 AGGRASTAT ® tirofiban hydrochloride 54 Acute myocardial infarction 54 TURBT 54 coronary microvascular 54 Skin rashes 54 carotid artery stenting CAS 54 desvenlafaxine succinate 54 Effexor venlafaxine 54 μmol L 54 vaso occlusive crisis 54 lethal arrhythmias 54 hepatic fibrosis 54 lymphocyte count 54 kidney allograft 54 operable breast cancer 54 Legg Calvé Perthes disease 54 uncircumcised males 54 somatoform disorders 54 systolic diastolic 54 stimulated insulin secretion 54 anemia hemoglobin 54 CIN3 54 gastro esophageal reflux 54 inducible nitric oxide synthase 54 cryptogenic 54 communicable chronic 54 bronchoalveolar lavage 54 seropositivity 54 clinically asymptomatic 54 tegaserod 54 urinary albumin excretion 54 dyspareunia 54 pmol L 54 noncardiovascular mortality 54 carcinomatosis 54 mcg BID 54 Uncontrolled hypertension 54 μg liter 54 Asymptomatic 54 Glomerular filtration rate 54 ischemic cerebrovascular 54 leptin deficiency 54 ADCS ADL 54 degenerative lumbar 54 postintervention 54 adverse perinatal 54 Familial hypercholesterolemia 54 cardiotoxic 54 Main Outcome Measure 54 multivessel disease 54 intrahepatic cholangiocarcinoma 54 testicular tumors 54 atheromatous 54 homocysteine concentrations 54 varenicline Chantix 54 genotype 1b 54 multivariable adjustment 54 glycoprotein IIb IIIa inhibitors 54 Ishak fibrosis score 54 nonsignificant 54 mcg ml 54 pericardial effusion 54 nonfatal myocardial infarction MI 54 HER2 positive cancers 54 statistically significant correlation 54 atherosclerotic progression 54 aldosterone antagonist 54 incomplete revascularization 54 inhaled corticosteroid therapy 54 thromboembolic complications 54 Fibromyalgia Impact Questionnaire 54 sargramostim 54 sitaxsentan 54 de novo coronary artery 54 monogenic 54 recurrent ischemic stroke 54 CFVR 54 tirofiban 54 bioprosthetic valve 54 Hazard Ratio 54 atelectasis 54 nulliparous women 54 Multivariate analysis 54 resynchronization therapy 54 cerebrovascular accident 54 periventricular leukomalacia 54 serum sodium levels 54 bladder cervix 54 benign thyroid nodules 54 atopic disorders 54 liver histology 54 genital herpes infections 54 parkinsonian 54 labetalol 54 sotalol 54 folate concentrations 54 medication nonadherence 54 interquartile range 54 clinicopathologic 54 CR nPR 54 serum triglyceride 54 cytopenias 54 intrathoracic 54 hepatic encephalopathy HE 54 severe hypoglycaemia 54 leukocytosis 54 hepatitis C genotype 54 invasive carcinomas 54 gene polymorphism 54 fetal malformations 54 chromium supplementation 54 arterial calcification 54 Catheter Associated 54 mesenteric 54 paroxysmal AF 54 metastatic lymph nodes 54 P ≤ 54 MMSE scores 54 pain catastrophizing 54 untreated celiac disease 54 ID TLR 54 drotrecogin alfa activated 54 Parathyroid hormone 54 cytotoxic therapies 54 Operative mortality 54 bisoprolol 54 Skin sterol 54 lobar 54 asthenia fatigue 54 underwent resection 54 androgen hormone 54 bronchopulmonary dysplasia BPD 54 eosinophil count 54 Lymphocytic 54 Fasting plasma glucose 54 anthropometric measures 54 nonpsychiatric 54 segment binary restenosis 54 neonatal morbidity 54 daytime somnolence 54 aphthous ulcers 54 abstinent alcoholics 54 AOR = 54 ASCUS 54 torsade de pointes 54 NSAID induced GI 54 acute postoperative 54 Endothelial function 54 statistically significant p 54 % CI #.#-#.# [005] 54 hypertensives 54 postoperative mortality 54 MCyR 54 thienopyridines 54 induced platelet aggregation 54 #OHD 54 lipohypertrophy 54 T2 lesion volume 54 endothelial activation 54 interstitial pneumonia 54 Nicotine dependence 54 mcg QD 54 hypoactive 54 metabolic dysfunction 54 LV systolic dysfunction 54 Target Lesion Revascularization TLR 54 Heavy snorers 54 multivariate logistic regression 54 ulcerative colitis Crohn disease 54 secondary hyperparathyroidism 54 intracranial stenosis 54 prognostic indicator 54 HER2 expression 54 intra abdominal abscess 54 hyperintensities